CC0000: The color(s) blue and light blue is/are claimed as a feature of the mark.
D10000: "IMAGE GUIDED THERAPY"
DM0000: The mark consists of a bent molecule feature composed of a larger light blue orb with blue shading connected with two smaller light blue orbs with blue shading, next to the stylized wording of "IMGT" in blue, over the stylized wording of "IMage Guided Therapy" where the letters, "IM" are in blue, "age" are in light blue, "G" are in blue, "uided" are in light blue, "T" are in blue, and "herapy" are in light blue.
GS0051: Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Enzymes for medical purposes; Pharmaceutical preparations acting on the central nervous system; Antibiotic preparations; Chemotherapeutics; Veterinary vaccines; Vaccines; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of CNS disorders; Pharmaceutical preparations for the treatment of peripheral vascular or neurologic disease; Pharmaceutical preparations for the treatment of lesions; Pharmaceutical preparations for reliving pain; Pharmaceutical preparations for activating drug delivery; Nutraceuticals for use as a dietary supplement for promoting digestion; Anti-cancer preparations
GS0101: Medical apparatus, namely, medical ultrasound apparatus; Medical apparatus, namely, ultrasound diagnostic apparatus; Medical instruments for use in general surgery; Medical apparatus for treating cancer; Medical apparatus for treating cancer by using ultrasound; Medical apparatus for treating CNS disorders; Medical apparatus for treating CNS disorders by using ultrasound; Medical apparatus for treating peripheral vascular or neurologic disease; Medical apparatus for treating peripheral vascular or neurologic disease by using ultrasound; Medical apparatus for treating dermatological disease by using ultrasound; Medical apparatus for treating dermatological disease; Medical apparatus for treatment of lesions; Medical apparatus for treatment of lesions through hyperthermia caused by using ultrasound; Medical apparatus for relieving pain; Medical apparatus for relieving pain by using ultrasound; Medical apparatus for activating drug delivery; Medical apparatus for activating drug delivery by using ultrasound; Syringes for medical purposes and for injections; Medical apparatus for detecting cancer; Dental instruments, namely, picks, burrs, mirrors, prophy angles, oral irrigators, crown and bridge removers; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Diagnostic apparatus for the detection of periodontal disease; Diagnostic apparatus for the detection of cancer; Medical diagnostic apparatus for detecting cancer; Injection device for pharmaceuticals; Syringes for medical purposes; Syringes for injection of medical substances; Hypodermic syringes
GS0421: Drug discovery services; Biotechnology research; Biomedical research services; Laboratory research in the field of biology; Providing information on the subject of scientific research in the field of Biochemistry and biotechnology; Biological research; Bacteriological research; Pharmaceutical research and development; Research on the subject of pharmaceuticals; Clinical research in the field of medicines for detection and treatment of cancer; Conducting clinical trials for others in the field of medicines for detection and treatment of cancer; Medical research services; Scientific research for medical purposes in the field of cancer; Testing of pharmaceuticals; Testing of materials; Chemical research and analysis; Chemical research services
Case File Event Statements
11/2/2021 - 3 years ago
23 - REGISTERED-PRINCIPAL REGISTERType:R.PR
8/17/2021 - 3 years ago
22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
8/17/2021 - 3 years ago
21 - PUBLISHED FOR OPPOSITIONType:PUBO
7/28/2021 - 3 years ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
7/12/2021 - 3 years ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
6/15/2021 - 3 years ago
18 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
6/15/2021 - 3 years ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
6/7/2021 - 3 years ago
16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVEDType:ERSI
3/22/2021 - 3 years ago
15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILEDType:GNS3
3/22/2021 - 3 years ago
14 - LETTER OF SUSPENSION E-MAILEDType:GNSL
3/22/2021 - 3 years ago
13 - SUSPENSION LETTER WRITTENType:CNSL
3/19/2021 - 3 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
3/19/2021 - 3 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
3/19/2021 - 3 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA